Annual FCF
-$136.20 M
+$41.51 M+23.36%
December 31, 2023
Summary
- As of February 8, 2025, RYTM annual free cash flow is -$136.20 million, with the most recent change of +$41.51 million (+23.36%) on December 31, 2023.
- During the last 3 years, RYTM annual FCF has fallen by -$14.01 million (-11.47%).
- RYTM annual FCF is now -1847.44% below its all-time high of -$6.99 million, reached on December 31, 2015.
Performance
RYTM Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
$14.79 M
+$83.86 M+121.40%
September 30, 2024
Summary
- As of February 8, 2025, RYTM quarterly free cash flow is $14.79 million, with the most recent change of +$83.86 million (+121.40%) on September 30, 2024.
- Over the past year, RYTM quarterly FCF has increased by +$55.53 million (+136.29%).
- RYTM quarterly FCF is now at all-time high.
Performance
RYTM Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$124.42 M
+$38.64 M+23.70%
September 30, 2024
Summary
- As of February 8, 2025, RYTM TTM free cash flow is -$124.42 million, with the most recent change of +$38.64 million (+23.70%) on September 30, 2024.
- Over the past year, RYTM TTM FCF has increased by +$16.05 million (+11.43%).
- RYTM TTM FCF is now -1673.32% below its all-time high of -$7.02 million, reached on March 31, 2017.
Performance
RYTM TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
RYTM Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +23.4% | +136.3% | +11.4% |
| 3 y3 years | -11.5% | +136.5% | +17.8% |
| 5 y5 years | -117.0% | +136.5% | +17.8% |
RYTM Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +23.4% | at high | +121.4% | at high | +32.5% |
| 5 y | 5-year | -11.5% | +23.4% | at high | +121.4% | -4.0% | +32.5% |
| alltime | all time | -1847.4% | +23.4% | at high | +121.4% | -1673.3% | +32.5% |
Rhythm Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $14.79 M(-121.4%) | -$124.42 M(-23.7%) |
| Jun 2024 | - | -$69.08 M(+69.5%) | -$163.06 M(+16.1%) |
| Mar 2024 | - | -$40.74 M(+38.7%) | -$140.47 M(+3.1%) |
| Dec 2023 | -$136.20 M(-23.4%) | -$29.38 M(+23.2%) | -$136.20 M(-3.3%) |
| Sep 2023 | - | -$23.86 M(-48.7%) | -$140.82 M(-14.2%) |
| Jun 2023 | - | -$46.48 M(+27.4%) | -$164.05 M(+2.3%) |
| Mar 2023 | - | -$36.48 M(+7.3%) | -$160.43 M(-9.7%) |
| Dec 2022 | -$177.71 M(+17.3%) | -$34.00 M(-27.8%) | -$177.71 M(-3.6%) |
| Sep 2022 | - | -$47.08 M(+9.8%) | -$184.25 M(+3.8%) |
| Jun 2022 | - | -$42.87 M(-20.3%) | -$177.43 M(+3.4%) |
| Mar 2022 | - | -$53.76 M(+32.6%) | -$171.65 M(+13.3%) |
| Dec 2021 | -$151.44 M(+23.9%) | -$40.54 M(+0.7%) | -$151.44 M(+8.1%) |
| Sep 2021 | - | -$40.27 M(+8.6%) | -$140.10 M(+10.3%) |
| Jun 2021 | - | -$37.09 M(+10.6%) | -$127.00 M(+6.2%) |
| Mar 2021 | - | -$33.54 M(+14.8%) | -$119.64 M(-2.1%) |
| Dec 2020 | -$122.19 M | -$29.21 M(+7.5%) | -$122.19 M(-2.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | -$27.16 M(-8.6%) | -$125.21 M(-5.1%) |
| Jun 2020 | - | -$29.73 M(-17.6%) | -$131.91 M(+1.4%) |
| Mar 2020 | - | -$36.10 M(+12.0%) | -$130.04 M(+3.1%) |
| Dec 2019 | -$126.14 M(+100.9%) | -$32.22 M(-4.9%) | -$126.14 M(+9.4%) |
| Sep 2019 | - | -$33.86 M(+21.5%) | -$115.29 M(+16.8%) |
| Jun 2019 | - | -$27.86 M(-13.4%) | -$98.69 M(+18.4%) |
| Mar 2019 | - | -$32.19 M(+50.6%) | -$83.32 M(+32.7%) |
| Dec 2018 | -$62.78 M(+112.1%) | -$21.38 M(+23.9%) | -$62.78 M(+27.2%) |
| Sep 2018 | - | -$17.26 M(+38.2%) | -$49.34 M(+21.6%) |
| Jun 2018 | - | -$12.49 M(+7.2%) | -$40.58 M(+18.5%) |
| Mar 2018 | - | -$11.65 M(+46.7%) | -$34.23 M(+15.7%) |
| Dec 2017 | -$29.59 M(+21.9%) | -$7.94 M(-6.5%) | -$29.59 M(+36.7%) |
| Sep 2017 | - | -$8.49 M(+38.3%) | -$21.65 M(+64.6%) |
| Jun 2017 | - | -$6.14 M(-12.5%) | -$13.16 M(+87.5%) |
| Mar 2017 | - | -$7.02 M | -$7.02 M |
| Dec 2016 | -$24.28 M(+247.1%) | - | - |
| Dec 2015 | -$6.99 M | - | - |
FAQ
- What is Rhythm Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals annual FCF year-on-year change?
- What is Rhythm Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals quarterly FCF year-on-year change?
- What is Rhythm Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Rhythm Pharmaceuticals?
- What is Rhythm Pharmaceuticals TTM FCF year-on-year change?
What is Rhythm Pharmaceuticals annual free cash flow?
The current annual FCF of RYTM is -$136.20 M
What is the all time high annual FCF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high annual free cash flow is -$6.99 M
What is Rhythm Pharmaceuticals annual FCF year-on-year change?
Over the past year, RYTM annual free cash flow has changed by +$41.51 M (+23.36%)
What is Rhythm Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of RYTM is $14.79 M
What is the all time high quarterly FCF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high quarterly free cash flow is $14.79 M
What is Rhythm Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, RYTM quarterly free cash flow has changed by +$55.53 M (+136.29%)
What is Rhythm Pharmaceuticals TTM free cash flow?
The current TTM FCF of RYTM is -$124.42 M
What is the all time high TTM FCF for Rhythm Pharmaceuticals?
Rhythm Pharmaceuticals all-time high TTM free cash flow is -$7.02 M
What is Rhythm Pharmaceuticals TTM FCF year-on-year change?
Over the past year, RYTM TTM free cash flow has changed by +$16.05 M (+11.43%)